Toremifene for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia: Results of a Double-Blind, Placebo Controlled, Phase IIB Clinical Trial - Concepedia

Concepedia

Publication | Closed Access

Toremifene for the Prevention of Prostate Cancer in Men With High Grade Prostatic Intraepithelial Neoplasia: Results of a Double-Blind, Placebo Controlled, Phase IIB Clinical Trial

171

Citations

18

References

2006

Year

David T. Price, Barry Stein, Paul Sieber, Ronald Tutrone, James L. Bailen, Erik T. Goluboff, Daniel Burzon, David G. Bostwick, Mitchell S. Steiner

The Journal of Urology

Abstract

Toremifene decreased the incidence of prostate cancer by 1 year and had a tolerability profile comparable to that of placebo in a high risk population.

References

	Year	Citations

Page 1